Open AccessPre-operative Early Hormonotherapy the New Gold Standard for Operable Luminal Breast Cancer
Publication year - 2020
Publication title -
international journal of cancer research and therapy
Language(s) - English
Resource type - Journals
ISSN - 2476-2377
DOI - 10.33140/ijcrt.05.02.02
Subject(s) - breast cancer , medicine , gold standard (test) , neoadjuvant therapy , chemotherapy , oncology , clinical practice , cancer , gynecology , family medicine
Even though it is not yet a universally accepted, in our view, the best clinical practice in the case of operable luminal breast cancer is to begin systemic neoadjuvant hormonotherapy (HT) immediately after histologic diagnosis for the majority of patients. This strategy does not apply to patients with an indication for neoadjuvant chemotherapy.